Table 1.
Parameter | N = 554 |
---|---|
Baseline Age (y) | 43 (37–48) |
Female | 167 (30%) |
Race | |
African American | 236 (43%) |
Caucasian | 266 (48%) |
Other | 52 (9%) |
History of CAD | 34 (6%) |
Cigarette smoking | |
Current | 206 (37%) |
Past | 123 (22%) |
Never | 225 (41%) |
Diabetes mellitus | 45 (8%) |
Systolic BP (mmHg) | 116 (107–124) |
Diastolic BP (mmHg) | 78 (71–85) |
Antihypertensive use | 114 (21%) |
Hypertension | 153 (28%) |
LDL (mg/dL) | 109 (79–137) |
HDL (mg/dL) | 41 (34–52) |
TG (mg/dL) | 153 (97–279) |
BMI (kg/m2) | 25 (22–28) |
Waist Circumference (cm) | 88 (81–97) |
Ever HAART use | 480 (87%) |
Current CD4 count | 385 (232–560) |
Nadir CD4 count | 126 (30–251) |
History of AIDS | 383 (69%) |
Plasma HIV RNA: | |
≤ 80 | 247 (45%) |
81–1999 | 120 (22%) |
2000–9999 | 59 (11%) |
>10000 | 128 (23%) |
Hepatitis C | 122 (22%) |
Current heroin use | 107 (20%) |
Albuminuria* | 95 (21%) |
ACR (mg/g) | 7.4 (4.8–17.3) |
eGFRCys< 60 | 47 (8%) |
eGFRCys(ml/min/1.73m2) | 86 (72–103) |
Data are presented as Median (IQR) or numbers (percent). ACR – albumin to creatinine ratio.
defined as a positive urine dipstick result (≥1+) or urine albumin-creatinine ratio >30 mg/g.